Edit |   |
---|---|
Antigenic Specificity | Phospho-Ser358 Eukaryotic Elongation Factor 1 alpha 2 (eEF1A2) |
Clone | polyclonal |
Host Species | Rabbit |
Reactive Species | mouse |
Isotype | n/a |
Format | peptide affinity purified |
Size | 0.1 mL |
Concentration | n/a |
Applications | Western Blot (WB) |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Specificity: Specific for the ~50k eEF1A2 phosphorylated at Ser358. Immunolabeling of the eEF1A2 band is blocked by the treatment of the lysate with lambda phosphatase (30 minutes, 800 units / 1 mg protein). Affinity purified rabbit polyclonal antibody |
Immunogen | Antigen: Phosphopeptide corresponding to amino acid residues surrounding the phospho-Ser358 of human eEF1A2. Immunogen Information: Synthetic phospho-peptide corresponding to amino acid residues surrounding Ser358 conjugated to KLH. Immunogen Species: Human |
Other Names | [elongation factor 1-alpha 2; Elongation factor 1-alpha 2; elongation factor 1-alpha 2; eEF1A-2; statin S1; statin-S1; elongation factor-1 alpha; eukaryotic elongation factor 1 A-2; eukaryotic translation elongation factor 1 alpha 2; Eukaryotic elongation factor 1 A-2; eEF1A-2; Statin-S1], [EEF1A2; EEF1A2; HS1; STN; EF1A; STNL; EEF1AL; EF-1-alpha-2; EEF1AL; STN; EF-1-alpha-2; eEF1A-2] |
Gene, Accession # | [EEF1A2], Gene ID: 1917, NCBI: NP_001949.1, UniProt: Q05639 |
Catalog # | MBS502182 |
Price | $360 |
Order / More Info | Phospho-Ser358 Eukaryotic Elongation Factor 1 alpha 2 (eEF1A2) Antibody from MYBIOSOURCE INC. |
Product Specific References | • Knudsen SM, Frydenberg J, Clark BF, Leffers H. Tissue-dependent variation in the expression of elongation factor-1 alpha isoforms: isolation and characterization of a cDNA encoding a novel variant of human elongation-factor 1 alpha. Eur J Biochem. 1993;215:549-554.• Anand N, Murphy s, Amann G, Wernick M, Porter LA, Cukier IH, Collins C, Gray JW, Diebold J, Demetrick DJ. Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nat Genet. 2002;31:301- 305.• Soares DC, Barlow PN, Newbery HJ, Porteous DJ, Abbot CM. Structural models of human eEF1A1 and eEF1A2 reveal two distant surface clusters of sequence variation and potential differences in phosphorylation. PLoS One. 2009 Jul 28;4(7):e6315.• Gandin V, Gutierrez GJ, Brill LM, Varsano T, Feng Y, Aza-Blanc P, Au Q, McLaughlan S, Ferreira TA, Alain T, Sonenberg N, Topisirovic I, Ronai ZA. Degradation of newly synthesized polypeptides by ribosomeassociated RACK1/c-Jun N-Terminal Kinase/Eukaryotic Elongation Factor 1A2 complex. 2013 Jul;33(13):2510-26. |